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Ichthyosis follicularis with atrichia and photophobia (IFAP syndrome) is a rare X-linked, oculocutaneous humandisorder. Here, we assign
the IFAP locus to the 5.4 Mb region between DXS989 and DXS8019 on Xp22.11-p22.13 and provide evidence that missense mutations
exchanging highly conserved amino acids of membrane-bound transcription factor protease, site 2 (MBTPS2) are associated with this
phenotype. MBTPS2, a membrane-embedded zinc metalloprotease, activates signaling proteins involved in sterol control of transcrip-
tion and ER stress response. Wild-type MBTPS2 was able to complement the protease deﬁciency in Chinese hamster M19 cells as shown
by induction of an SRE-regulated reporter gene in transient transfection experiments and by growth of stably transfected cells in media
devoid of cholesterol and lipids. These functions were impaired in ﬁve mutations as detected in unrelated patients. The degree of dimin-
ished activity correlated with clinical severity as noted in male patients. Our ﬁndings indicate that the phenotypic expression of IFAP
syndrome is quantitatively related to a reduced function of a key cellular regulatory system affecting cholesterol homeostasis and ability
to cope with ER stress.Introduction
IFAP syndrome (MIM 308205) is an X-linked oculocutane-
ous human disorder characterized by a peculiar triad of
follicular ichthyosis, total or subtotal atrichia, and photo-
phobia of varying degree (Figure 1).1 Histopathologically,
the epidermal granular layer is generally well-preserved
or thickened at the infundibulum. Hair follicles are poorly
developed and tend to be surrounded by an inﬂammatory
inﬁltrate. A subgroup of patients is described with lamellar
rather than follicular ichthyosis. Well-demarcated psoriasi-
form plaques in addition to, or instead of, follicular
ichthyosis are also described.2,3 Congenital atrichia is the
most prominent feature of the syndrome. In most of the
affected boys, total atrichia is noted at birth. Occasionally,
some sparse and thin hair may be present.4,5 The third
constant feature is photophobia possibly due to vasculariz-
ing keratitis or to anomalies in Bowman’s membrane
combined with intracellular epithelial adhesion defects.6
Nonconsistent ﬁndings include neurological abnormali-
ties such as retarded psychomotor development, cerebral
atrophy, temporal lobe malformation, and hypoplasia of
corpus callosum,7 failure to thrive, nail dystrophy, atopic
manifestations, inguinal hernia, and aganglionic megaco-
lon, as well as renal, vertebral, and testicular anomalies.2,8,9
X linkage was predicted because the full phenotype is
found in males only. Female carriers may present with
a linear pattern of follicular ichthyosis, mild atropho-
derma, hypotrichosis, and hypohidrosis. These lesionsclearly follow the lines of Blaschko.10 In other obligate
carrier females, extreme lyonization may give rise to non-
penetrance, thus blurring the difference between recessive
and dominant X-linked inheritance. The rarity of IFAP
syndrome has previously hampered genetic mapping. In
this report, we show that IFAP syndrome is caused by func-
tional deﬁciency of membrane-bound transcription factor
protease, site 2 (MBTPS2 [MIM 300294]), a membrane-
embedded zinc metalloprotease that activates signaling
proteins involved in sterol control of transcription and
ER stress response.
Material and Methods
Study Subjects
This study included three extended multigeneration pedigrees as
well as two unrelated male patients (4-I:1 and 5-I:1), all of Euro-
pean descent, and two affected brothers (6-II:1 and 6-II:4) from
an Algerian family (Figure 2 and Table 1). Patient 4-I:1 had amildly
affected mother who was unavailable for molecular analysis. DNA
from the clinically unaffected mother (6-I:2) of patients 6-II:1 and
6-II:4 was included in the mutation analysis. Patient 5-I:1 had
been mentioned as individual IV:8 in a pedigree reported previ-
ously.2 Examination of medical records and mutation analyses
were carried out under research protocols approved by the local
ethics committee of the University of Marburg. Informed consent
was obtained from patients, their parents, and controls. A total of
140 control DNA samples (225 X chromosomes) were taken from
healthy individuals with self-reported European ancestry.1Department of Human Genetics, Philipps-Universita¨t, Marburg 35037, Germany; 2The Northern Clinical School, University of Sydney, St Leonard’s
NSW 2065, Australia; 3Department of Dermatology, Philipps-Universita¨t, Marburg 35037, Germany; 4Department of Human Genetics, Rheinische
Friedrich-Wilhelms-Universita¨t, Bonn 53111, Germany; 5Department of Dermatology, University of Algiers, Algiers 16030, Algeria; 6Department of
Dermatology, Hospital del Nin˜o Jesu´s, San Miguel de Tucuma´n 4000, Argentina; 7Dermatologist, C/Violeta 9D3, Fuengirola (Ma´laga) 29640, Spain;
8Department of Dermatology, Hospital Carlos Haya, Ma´laga 29010, Spain
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Cell Culture
CHO-M19 cells, a mutant line of CHO-K1 cells, auxotrophic for
cholesterol and unsaturated fatty acids owing to a deletion in
the S2P-gene,11,12 a generous gift of T.Y. Chang (Dartmouth
Medical School, Hanover, NH, USA) were maintained under stan-
dard conditions in F12 media supplemented with 10% FCS,
nonessential amino acids, and antibiotics.
Recombinant Plasmids
Vectors expressing MBTPS2 mutants as fusion proteins with
Yellow Fluorescent Protein (EYFP) were derived by mutagenesis
via directional PCR product cloning from the full ORF expression
clone IOH46558-pdEYFP-C1amp13 (imaGenes GmbH). For stable
transfection, the EYFP-MBTPS2 wild-type or mutant fusion genes
were subcloned into the pcDNA3.1-vector expressing a neomycin
(G418) resistance gene (Invitrogen). A reporter plasmid pSRE-
GL4.23 was generated in the expression vector pGL4.23[luc2/
minP] (Promega) by inserting in tandem three copies of repeat
2þ3 of the human LDL receptor promoter (Sterol Regulatory
Element, SRE)14 upstream of the minimal promoter driving the
Fireﬂy-luciferase gene. The control luciferase plasmid pRL-SV40
(Renilla-luciferase driven constitutively by an SV40 promoter
and enhancer) was obtained from Promega.
Genetic Mapping
Genomic DNA was extracted from peripheral blood lymphocytes
in accordance with standard procedures and taken as a template
for polymerase chain reaction (PCR).
Figure 1. Clinical Features of IFAP Syndrome
Male patient showing typical filiform follicular hyperkeratoses
(‘‘ichthyosis follicularis’’) (A), atrichia of the scalp (B), half-closed
eyelids reflecting severe photophobia, and absence of eyebrows
and lashes (C).460 The American Journal of Human Genetics 84, 459–467, April 10For linkage analysis, we PCR-ampliﬁed 11 X-chromosomal mi-
crosatellite markers from the CHLC screening set ver. 6 using,
with minor modiﬁcations, the conditions described in the
Genome Database (GDB: DXS6807, DXS8022, DXS989,
DXS1068, DXS1003, DXS7132, DXS6800, DXS8020, DXS1001,
DXS1047, and DXS1193). The mean heterozygosity was >0.8.
Allele sizes were standardized by comparison with individual
1347MO2 (Centre d’E´tudes du Polymorphisme Humain, CEPH).
Locus order and sex-averaged intermarker distances (8.44 cM on
average) were used as provided by the Center forMedical Genetics,
Marshﬁeld Medicine Research Foundation. Corresponding allele
frequencies were adopted from GDB, where possible, or set to be
equally distributed (DXS7132 and DXS6800). A dense grid of
ﬁve highly polymorphic microsatellite markers was used for ﬁne
mapping on chromosome Xp21-p22.1 covering a distance of
12.5 Mb (DXS8019, DXS7593, DXS1226, DXS989, and DXS8039).
For genetic mapping, we assumed an X-linked recessive mode of
inheritance with 90% penetrance in female carriers and nearly
complete penetrance (0.999) in affected males. Phenocopies
were virtually excluded (0.001). The disease allele frequency was
adjusted to 1:100.000.
Software Applied in Linkage and Haplotype Analyses
Parametric two-point linkage analyses were undertaken as
described previously.15,16 LOD-score calculations were performed
for each marker with the MLINK program of LINKAGE package,
ver. 5.10. Multipoint analyses were performed for all the microsa-
tellite markers employing the MINX program of MERLIN, ver.
1.0.1.17 MINX was also used to generate haplotypes.
HR-CGH: Microarray Construction and Probe
Selection
Arrays for high resolution comparative genome hybridization
(HR-CGH) covering the entire X chromosome were generated at
NimbleGen Systems as described previously.18 The arrays were
hybridized with Cy3-labeled genomic DNA samples from six unre-
lated IFAP patients (1-III:1, 2-III:1, 3-II:2, 4-I:1, 5-I:1, and 6-II:1;
Table 1) in comparison with standard samples. Copy number vari-
ants were then searched by automated segmentation analysis of
the signal data sets and visualized with the SignalMap software
tool provided by NimbleGen.18
Mutation Analysis of Candidate Genes
Candidate genes MBTPS2, PTCHD1 (accession number
NM_173495), SCML1 (MIM 300227), RAI2 (MIM 300217), and
YY2 (MIM 300570), selected because of their inferred biological
relevance for IFAP syndrome, were sequenced in the same six
unrelated patients. Primer pairs used for ampliﬁcation of the
coding exons of PTCHD1, SCML1, RAI2, and YY2 are available
on request. Primer pairs and PCR conditions for the ampliﬁcation
of the coding exons ofMBTPS2 including the intron-exon bound-
aries are listed in Table S2 available online.We used the same oligo-
nucleotides to sequence the PCR products on both strands.
Mutations in the coding exons of MBTPS2 were conﬁrmed by
independent methods such as an Ampliﬁcation Refractory
Mutation System (ARMS test, family 1 and individual 6-II:1),
single-strand conformation analysis (SSCA, family 2), and muta-
tion-speciﬁc restriction enzyme digestion (family 3 with restric-
tion enzyme TaiI, individual 4-I:1 with BstXI, and individual
5-I:1 with Eco130I. To exclude mutations that represented
single-nucleotide polymorphisms (SNPs), we scrutinized DNA, 2009
samples representing 225 X chromosomes from unrelated control
individuals by the same procedures and searched the sequence of
the mutated allele in NCBI dbSNP.
Histochemical Analysis of Cells Transiently
Transfected with EYFP-MBTPS2 Expression Plasmids
Chinese hamster K1 cells and transformed African Green Monkey
kidney ﬁbroblast cells (COS-7 line) were cultured in Ham’s F-12 or
DMEM medium, respectively, supplemented with nonessential
amino acids and glutamine, 100 units/ml of penicillin, 100 mg/ml
streptomycin, and 10% fetal calf serum (FCS). A total of 2 3 105
cells each were seeded in 1 ml per well of two-well Lab-Tek
chamber slides. Transfection complexes composed of 4 ml Turbo-
Fect (MBI Fermentas), and 500 ng of wild-type or mutant
YFP-MBTPS2 recombinant expression construct DNA were mixed
in 500 ml culture medium without serum, incubated for
Figure 2. Pedigrees of Three Families
of European Descent with IFAP Syndrome
Partial pedigrees of families 1–3 show
genotypes of X-chromosomal markers from
Xpter to Xcen. Disease-associated haplo-
types in families 1 and 2 are encased in
a box. For clarity, not all analyzed markers
listed in Table S1 are given. MBTPS2 muta-
tions and the derived amino acid changes
are indicated below the family identifier
and are included as allele ‘‘mt’’ in the list
of genotypes; ‘‘wt’’ represents wild-type
MBTPS2. The status of females as unaf-
fected carriers in families 2 and 3 is defined
a posteriori according to the presence of
a mutated MBTPS2 allele.
10–15 min at room temperature to allow
formation of transfection complexes, and
subsequently added drop wise to the cells
in each of the wells. The cells with the
transfection complexes were incubated
under normal growth conditions. After
12 hr, the medium was replaced with fresh
growth media containing 10% FCS, and
incubation was continued for 12 hr. Subse-
quent ﬂuorescence microscopy detected
in parallel the intracellular localization of
YFP or YFP-tagged MBTPS2, DAPI-stained
nuclei, and Golgi vesicles stained with
monoclonal mouse golgin-97 antibody
(Molecular Probes/Invitrogen: A21270,
1:200) and Alexa Fluor 594 goat anti-
mouse immunoglobulin (MolecularProbes/
Invitrogen: A11005) as secondary antibody
(diluted 1:500). Immunostained cells
were again washed thoroughly with PBS/
0.5% Tween 20 and mounted in an anti-
fade reagent with DAPI for staining
of nuclei (Molecular Probes/Invitrogen:
S30939). Images were taken on a Zeiss
Axioplan microscope (Carl Zeiss MicroI-
maging GmbH) with a Leica DFC 300 FX
camera (Leica Microsystems), and processed with the Leica
imaging system 50 (IM50) software.
Luciferase Reporter Assays
This assay, an indirect measure of the ability of MBTPS2 cDNAs
to restore sterol-regulated transcriptional activity in transfected
M19 cells with a pSRE-Luciferase reporter plasmid, essentially fol-
lowed the rationale outlined by Zelenski and coworkers.19 A total
of 1.5 3 105 M19 cells per well were set up in triplicate in 12-well
plates in a 1:1 mixture of Ham’s F-12 medium and Dulbecco’s
Modiﬁed Eagle Medium (DMEM) containing GlutaMax (Invitro-
gen), nonessential amino acids, penicillin, streptomycin (Medium
A), supplemented with 5% fetal calf serum, and maintained at
37C, 5% CO2. After 16 hr, the cells were washed once with PBS,
and incubation was continued with 2 ml of medium A with 5%
lipoprotein-deﬁcient fetal calf serum (medium B) supplemented
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Table 1. Clinical Features and MBTPS2 Genotypes of IFAP Patients and Family Members
Proband Origin Sex Clinical Features Genotype
1-I:1 G m n.a. WT
1-I:2 G f dry skin, congenital bald patches of the scalp c.680T/WT
1-I:3 G m n.a. WT
1-II:1 G m n.a. WT
1-II:2 G f dry skin, congenital bald patches of the scalp, asymmetrical distribution of body hair,
linear lesions of scaling, atrophy and hypohidrosis on arms and back
c.680T/WT
1-II:3 G m n.a. WT
1-II:4 G m n.a. WT
1-II:5 G m IFAP triad with pronounced photophobia; death at 1 year of age. n.t.
1-III:1 G m IFAP triad, eczematous changes of shoulders and limbs, frequent skin infections,
nail dystrophy, ptosis of left upper eyelid
c.680T
1-III:2 G f dry skin, linear lesions of scaling and atrophy, predominantly involving the left arm,
congenital bald area of the scalp
c.680T/WT
2-I:2 A f sparse hair c.261A/WT
2-II:2 A f unaffected carrier c.261A/WT
2-II:3 A f n.a. WT/WT
2-II:5 A m n.a. WT
2-II:7 A m n.a. WT
2-II:8 A m alopecia, dystrophic finger nails c.261A
2-III:1 A m IFAP triad, psoriasiform plaques on elbows, knees and heels, absence of eyebrows,
dystrophic nails, recurrent skin infections, no neurological anomalies
c.261A
2-III:2 A f sparse scalp hair, dystrophic fingernails c.261A/WT
2-III:4 A f n.a. WT/WT
2-III:5 A f n.a. WT/WT
2-III:6 A f n.a. WT/WT
2-III:7 A f n.a. WT/WT
2-III:8 A m n.a. WT
2-III:9 A f patchy scalp hair, dystrophic fingernails c.261A/WT
2-III:10 A f unaffected carrier c.261A/WT
2-III:11 A m n.a. WT
2-III:12 A m n.a. WT
2-IV:1 A m n.a. WT
2-IV:2 A m IFAP triad, dystrophic nails, perle`che c.261A
3-I:2 G f dry skin c.1286A/WT
3-II:2 G f linear lesions of atrophoderma, linear hairless scalp lesion, hyperkeratotic plaque
on right knee, bilateral plantar keratoderma
c.1286A/WT
3-II:4 G f linear lesions of atrophoderma, partial absence of retinal rods (R eye) c.1286A/WT
3-II:5 G f unaffected carrier c.1286A/WT
3-II:6 G m atrichia, cleft hand, death in neonatal period n.t.
3-II:7 G m atrichia, cleft hand, death in neonatal period n.t.
3-III:1 G f unaffected carrier c.1286A/WT
3-III:2 G f n.a. WT/WT
3-III:3 G m IFAP triad, initially in the form of collodium baby; dermatitis on arms and legs,
sensitiveness to cow’s milk, motor retardation, general dystrophy, cleft palate,
unilateral cleft hand, two butterfly vertebrae, absence of a kidney, bilateral inguinal
hernia, omphalocele, stenosis of small intestine, Hirschsprung disease, death at
9 months of age
n.t.
3-III:4 G m IFAP triad, microcephaly, arachnoidal cyst, Arnold-Chiari malformation type I,
thoracolumbar hydromyelia, seizures, psychomotor retardation, retrognathia, deficient
growth, cleft hands, butterfly vertebra, wedge-shaped vertebra, atrial septum defect,
arterial hypertension, recurrent infections of upper airways, absence of a kidney,
hypospadia, choanal stenosis, inguinal hernia, Hirschsprung disease; death at
14 months of age
n.t.
4-I:1 S m IFAP triad with pronounced photophobia, dermatitis on arms and legs, corneal pannus
(mother has dry skin and bald patches on her scalp)
c.677T
5-I:1 Ar m IFAP triad, hyperkeratosis around joints, perle`che, perianal erythema, plantar
keratoderma, subungual hyperkeratoses, periungual erythema and hyperkeratosis,
inguinal hernia, cryptorchidism
c.1424C
6-I:2 Al f n.a. c.225-6A/WT
6-II:1 Al m IFAP triad c.225-6A
6-II:4 Al m IFAP triad c.225-6A
IFAP triad: generalized scaling, complete atrichia, and photophobia. Al, Algeria; Ar, Argentina; A, Australia; G, Germany; S, Spain; n.a., not affected; n.t.,
not tested; WT, wild-type.
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with 20 mM sodium oleate. After 7 hr, we transfected the M19 cells
by adding to each well a transfection mixture containing 200 ml
serum-free F12/DMEM, 2 ml TurboFect in vitro Transfection
Reagent (MBI Fermentas), 500 ng of an expression plasmid
without MBTPS2 cDNA insert (pdEYFP-C1amp, kindly provided
by Dr. S. Wiemann, Heidelberg) or a wild-type or mutant EYFP-
tagged MBTPS2 cDNA together with 400 ng of pSRE-GL4.23
reporter plasmid, and 50 ng of pRL-SV40 as control for transfection
efﬁciency. After incubation for 3 hr at 37C, 5%CO2, the cells were
switched to medium B containing 50 mM sodium mevalonate and
50 mM sodium compactin, either supplemented with 10 mg/ml
water-soluble cholesterol, 1 mg/ml 25-hydroxycholesterol or
without sterols. After 16 hr at 37C, 5% CO2, cell lysates were
prepared and analyzed for Fireﬂy- and Renilla-luciferase activities
in a luminometer Auto Lumat LB953 (Berthold Technologies)
with a dual luciferase reporter assay system as suggested by the
supplier (Promega). These experiments were repeated three times.
Complementation Analysis: Growth of Stably
Transfected M19 Cells in Sterol-Deﬁcient Medium
A total of 106 CHO-M19 cells, each, were set up in 75 ml cell-
culture ﬂasks in medium A, supplemented with 10% FCS, and
transfected with 1.5 mg of a plasmid (pcDNA3.1, Invitrogen)
expressing a neomycin (G418) resistance gene alone or together
with EYFP-MBTPS2 wild-type or mutant fusion genes in accor-
dance with the procedure described for luciferase reporter assays.
Stable transfectants were selected by growth for 14 days at 37C,
5%CO2 inmediumC, amixture ofmediumA, 5% fetal calf serum,
water-soluble cholesterol (5 mg/ml), sodium mevalonate (1 mM),
and sodium oleate (20 mM), supplemented with 750 mg/ml
G418. This medium was replaced every 1–3 days. A total of 105
CHO-M19 cells stably transfected with tagged wild-type or one
of ﬁve mutantMBTPS2 genes were seeded in 5.5 cm diameter Petri
dishes and grown for 6 days at 37C, 5% CO2 in medium B or C,
respectively, each supplemented with 500 mg/ml G418. At day 6,
the cells surviving in the Petri dishes were washed once with
PBS, ﬁxed for 15 min in 4% PFA in PBS, washed brieﬂy in distilled
water, stained for 20 min in 1% Crystal Violet, washed again three
times in water, dried, and photographed for documentation. To
quantify the number of cells able to grow in sterol-depletedmedia,
these experiments were repeated three times in 75 ml cell-culture
ﬂasks. On day 6, the surviving cells were harvested and their
number was determined in a hemocytometer.
Results
To map the IFAP locus by parametric linkage analysis,
identify the gene responsible for the trait, and study func-
tional deﬁciencies that might explain the phenotype, we
analyzed three families of European descent (families
1, 2, and 3) in which IFAP segregated according to an
X-linked pattern of transmission, as well as IFAP patients
from three unrelated families (families 4, 5, and 6) (Figure 2
and Table 1). Only minor intrafamilial phenotypic vari-
ability between male patients was observed, whereas in
different families, the clinical severity of the syndrome
varied to a large degree. Affected males of family 2 mainly
displayed the IFAP triad of symptoms comprising total
alopecia, ichthyotic scaling (sometimes with psoriasiformThe Amplaques), and mild or severe photophobia. Individual
1-II:5 was completely hairless and avoided daylight because
of severe photophobia.10 Patient 4-I:1 showed similar
features. In contrast, male patients of families 3 and 5
suffered from a more severe form of IFAP syndrome. Indi-
viduals 3-II:6, 3-II:7, 3-III:3, and 3-III:4 had multiple addi-
tional malformations and died within 2 years after birth.
Male patients from family 4 had seizures, mental retarda-
tion, and inguinal hernia in addition to the IFAP triad.2
Female carriers in all families were either phenotypically
normal or showed rather mild symptoms such as asym-
metric distribution of body hair, patchy alopecia, or linear
lesions of follicular ichthyosis after the lines of Blaschko
(Table 1).
Employing genotyping results from families 1 and 2, we
assigned the IFAP locus by linkage analysis to the 5.5 Mb
region between DXS989 and DXS8019 in Xp22.11-
p22.13, encompassing approximately 35 known and
predicted genes (Figure 2, Figure 3, and Table S1).
Because array CGH did not detect any copy number
variants in this region (data not shown), candidate genes
were searched for mutations in genomic DNA of six unre-
lated IFAP patients. In ﬁve patients missense mutations
exchanging highly conserved amino acids were identiﬁed
in the gene MBTPS2 at Xp22.11 by sequencing the coding
exons including intron-exon boundaries from genomic
DNA ampliﬁed by PCR (family 1: c.680A/T; p.H227L;
family 2: c.261G/A; p.M87I; family 3: c.1286G/A;
p.R429H; family 4: c.667G/T; p.W226L; family 5:
c.1424T/C; p.F475S; Table 1, Figure 4, and Figure S1A).
In family 6, a c.225-6T/A transition introduced a putative
splice acceptor site in intron 2. SpliceView, an online
system for splice-site prediction, predicted this site is
used with similar probability as the wild-type sequence
6 bp upstream, implicating that it may lead to a frame shift
and consequently a truncated gene product consisting of
74 amino acid residues. Usage of this site might reduce
the amount of functional MBTPS2. Cells of these patients
were unavailable for conﬁrmation of functional MBTPS2
deﬁciency. The mutations, each, were conﬁrmed by inde-
pendent methodology listed above (data not shown).
They were not detected in 225 X chromosomes of unre-
lated individuals nor listed in NCBI dbSNP as known
SNPs. In male individuals, the MBTPS2 mutations segre-
gated with the IFAP phenotype. In addition to female
carriers showing clinical features of the syndrome, also obli-
gate carriers without IFAP symptoms and females for whom
the carrier statuswasnotpredictable from thepedigreewere
heterozygous for the mutations (Figure 2 and Table 1).
The exchange of highly conserved amino acids in
MBTPS2, an intramembrane zinc metalloprotease essential
for cholesterol homeostasis and ER stress response, and the
segregation of the missense mutations with the phenotype
suggest a causative role of enzyme dysfunction in IFAP
syndrome (Figure 2 and Figure S1). We tested the effect
of the ﬁve MBTPS2 missense mutations detected in IFAP
patients on the cellular localization of the enzyme inerican Journal of Human Genetics 84, 459–467, April 10, 2009 463
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Figure 3. Multipoint Linkage Analysis
of the IFAP Locus
Combined parametric multipoint linkage
analysis with the MINX program of MERLIN
confirms the two-point linkage results
placing the IFAP locus between DXS8019
and DXS989 (Table S1).
(A) Table and graphical representation
of multipoint LOD scores calculated with
X-chromosomal marker genotypes of pedi-
grees 1 and 2 (Figure 2). The highest LOD
score of 3.60 at DXS7593 is marked in bold.
(B) NCBI RefSeq genes (adopted from the
UCSC genome browser) from the critical
interval on the X chromosome between
markers DXS8019 (telomeric) and DXS989
(centromeric).cultured cells and on the potential to complement S2P
deﬁciency in Chinese hamster CHO-K1-M19 cells. Tran-
sient transfection of molecular YFP-fusion constructs
with WT or mutated MBTPS2 into cultured cells resulted
in the synthesis of ﬂuorescent proteins which localized
preferentially to the endoplasmatic reticulum. None of
the mutations interferes with synthesis or cellular localiza-
tion of the proteins (Figure 5A). M19 cells in which the
orthologousMbtps2 is deleted are unable to grow in choles-
terol and lipid-deﬁcient culture media.11,12 Wild-type
MBTPS2 stably transfected into M19 cells complemented
this defect and restored wild-type growth characteristics
(Figure 5B). None of ﬁve mutants detected in IFAP patients
has retained this property comparably to the wild-type
gene; however, a great variation in residual activity was
observed. Inmutants R429H and F475S, almost no survival
was detected (Figure 5B).When correlated to the severity of
the clinical phenotype it is evident that these mutants
with little residual growth potential are observed in themost seriously affected male patients (Table 1). Because
M19 cells are deﬁcient in S2P as a result of a genomic rear-
rangement that disrupts Mbtps2, they fail to process
SREBPs in response to cholesterol deprivation.11,12 A lucif-
erase reporter gene under transcriptional control of sterol
responsive elements (SRE) was active in cells grown in
sterol-deﬁcient media when wild-type MBTPS2 was co-
transfected (Figure 5C). However, sterol responsiveness of
the cells transfected with the mutants was restored to
a lower extent than with wild-type and differed consider-
ably among the mutants (Figure 5C). No signiﬁcant differ-
ence was obtained between the wt and the H227L mutant.
The lowest residual activity was retained inmutant R429H.
Discussion
MBTPS2 codes in 11 exons for a membrane-embedded zinc
metalloprotease, generally named site-2-protease (S2P),Figure 4. MBTPS2 Mutation Analysis
DNA sequence electropherograms of WT
MBTPS2 and mutations observed in male
or female IFAP patients from six unrelated
families. The positions of the mutant bases
are indicated by arrows. Phenotypes of the
individuals analyzed are listed in Table 1.
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Figure 5. Cellular Localization and
Complementation Analysis of MBTPS2
Mutant Proteins
(A) In cultured cells transiently transfected
with clones expressing YFP alone (vector),
with clone IOH46558-pdEYFP-C1amp ex-
pressing a YFP-MBTPS2-wild-type protein
(WT), or with five clones expressing
mutated YFP-MBTPS2 proteins as indicated
at the bottom of (C), the YFP-MBTPS2
fusion proteins localize preferentially in
the cytoplasm but not in the nucleus,
whereas YFP is found both in nucleus and
cytoplasm (green fluorescence, upper
panel). For clarity, nuclei are stained in
blue with DAPI; the Golgi shows red color
and is orange in superposition with green
fluorescence (lower panel).
(B) Stable transfection of CHO-K1-M19
cells lacking hamster Mbtps2 with WT
human MBTPS2 complements the enzyme
defect, thereby allowing growth in choles-
terol-deficient media. Complementation
analysis with either of five mutants
exchanging highly conserved amino acids
indicated at the bottom of (C) supports
growth in cholesterol-deficient media to
various degrees correlated with the
severity of the phenotype (Table 1). The
proportion of cells capable of growth in
spite of cholesterol deprivation is docu-
mented as photographs of the cultures in
absence or presence of sterols and, graph-
ically, by counts of growing stably trans-
fected cells under the same conditions.
Data are represented as mean 5 SEM.
Absence of sterols in the culture media is
indicated by a red frame encasing the
photographs of culture dishes and red columns in the diagrams; growth in media with sterols is indicated by blue frame or columns.
(C) Transient cotransfection of a construct expressing wild-type MBTPS2 (WT) with a luciferase reporter gene under transcriptional control
of sterol responsive elements (SRE) into M19 cells restores sterol responsiveness of the cells in sterol-deficient media (red columns) but
not in sterol-containing media (blue columns). Replacement of the wild-type with mutant MBTPS2 expression constructs results in
reduced induction by sterols to different extent. Transfection efficiency is normalized to cotransfected Renilla luciferase. The results
shown are representative of three independent transfection experiments. Data are represented as mean 5 SEM.
In (A)–(C), ’’Vector’’ represents different empty vectors used to clone WT and mutant MBTPS2 as described in Material and Methods.which cleaves within Golgi membranes after a ﬁrst luminal
proteolytic cut by site-1-protease (MBTPS1), cytosolic frag-
ments from prospective signaling proteins such as the
transcription factors SREBF1 and SREBF2 (MIM 184756
and MIM 600481), a prerequisite for their transport to
the nucleus and for sterol control of target gene transcrip-
tion.20 The same pair of proteases appears to control
unfolded protein response (UPR) within the endoplas-
matic reticulum by cleavage of membrane-bound tran-
scription factors, serving as putative ER stress sensors,
such as ATF6 (MIM 605537), CREB3L1 (GeneID 90993),
or CREB3L4 (MIM 607138).21–23
Deﬁciency in either function, sterol or ER homeostasis,
could lead to disturbed differentiation of epidermal struc-
tures evoking the triad of ichthyosis follicularis, atrichia,The Amand photophobia in the IFAP phenotype: SREBF2 signaling
is required for cholesterol biosynthesis. Many of the
ichthyoses are associated with inherited disorders of lipid
metabolism, mostly as a consequence of abnormal skin
permeability barrier function causing pathophysiology
through stimulation of epidermal hypoplasia (reviewed
by Elias et al.24). For example, in recessive X-linked
ichthyosis (XLI [MIM 308100]), because of mutation of
the gene for steroid sulfatase (STS [MIM 300747]), accumu-
lation of the amphipathic lipid cholesterol sulfate, the
substrate of this enzyme, provokes both a typical scaling
phenotype and permeability barrier dysfunction.25 Like-
wise, genetic defects in enzymes of the Kandutsch pathway
result in disorders associated with ichthyosiform lesions
and atrichia such as deﬁciency of NSDHL (NADPH steroiderican Journal of Human Genetics 84, 459–467, April 10, 2009 465
dehydrogenase-like protein [MIM 300275]) in CHILD
syndrome (MIM 308050)26 and of emopamil-binding
protein (EBP [MIM 300205]) in Conradi-Hu¨nermann-
Happle syndrome (CDPX2 [MIM 302960]).27
Photophobia in IFAP patients, similarly, is caused by an
epithelial disturbance. Ulceration and vascularization
lead to progressive corneal scarring and subsequent photo-
phobia. Ultrastructural ﬁndings suggest a primary defect of
epithelial adhesion at the corneal epithelial-stromal junc-
tion with anomalies of desmosomes, tonoﬁlaments, and,
subsequently, basement membrane and anchoring ﬁbrils
causing secondary changes in the corneal stroma. Such
changes include deposition of diffusely arranged elec-
tron-dense amyloid material, degenerated keratocytes
(mesenchymal cells) with cytoplasmic vesicles, and
thinned collagen ﬁbrils.6,28 These features may reﬂect
a deﬁciency of unfolded protein response in the ER.
The measurements of sterol responsiveness indicate that
the sterol regulatory element-binding protein site 2
protease activity of the MBTPS2 enzyme is diminished as
a consequence of the IFAP mutations. MBTPS2 belongs
to a family of HEXXH-containing zinc endopeptidases.
In these enzymes, the catalytic zinc atom, typically, is
located in the interphase between two alpha helices. One
helix contains the HEXXH sequence, and the other
contains a glutamic acid that also coordinates with the
zinc atom. In MBTPS2 both motifs are located in hydro-
phobic segments of the protein predicted to be adjacent
in the Golgi membrane.19 The mutations detected so far
do not affect the HEIGH motif or the LD467G sequence
coordinating the zinc at the active site of the enzyme
(Figure S1). However, when projected upon a hypothetic
model of MBTPS2,19 the interfamilial phenotypic differ-
ences between male IFAP patients and the properties of
the mutants in functional assays invite predictions about
a genotype-phenotype correlation: clinical severity in
male IFAP patients may range from mild forms of the triad
of ichthyosis follicularis, atrichia, and photophobia, which
can be categorized as a deﬁciency in epithelial develop-
ment compatible with survival and fertility of male
patients as evident in family 2, to severe manifestations
which, in addition to these features, include mental retar-
dation and various developmental defects that may even
cause early death (families 3 and 5). It appears that muta-
tions close to the hydrophobic, presumably intramembra-
nous domain encompassing the LDG motif at the active
site are more detrimental to development than an amino
acid exchange in the amino-terminal part of the protein
(Figure S1).
The spectrum of potential substrates for MBTPS2 has not
fully been elucidated. Therefore, it is premature to specu-
late whether the demonstrated effect upon sterol-regulated
expression is the predominant deﬁciency in all patients or
whether activation of different transcription factors by
binding and cleavage via the S1P/S2P mechanism is
affected by structural changes within critical motifs. Detec-
tion of further mutations in MBTPS2 associated with466 The American Journal of Human Genetics 84, 459–467, April 10meticulous clinical description of male IFAP patients,
unveiling of the crystal structure of the protease, and
progress in understanding of the biochemical mechanism
of its enzymatic action must be awaited to substantiate
genotype-phenotype predictions.
Functional MBTPS2 appears to be essential for develop-
ment. Consequently, deletions of this gene in all cells of
a male embryo might not be tolerated. As recently shown
for the X-linked dominant, male-lethal trait focal dermal
hypoplasia (FDH [MIM 305600]), complete loss of an
essential function in male patients is only compatible
with survival when present as a postzygotic mosaic or in
males with more than one X chromosome.18 Accordingly,
a mosaic situation should be considered in sporadic male
IFAP patients in which mutations in MBTPS2 are not
detected in DNA from blood.
The notion that, at least, a residual protease activity is
needed for survival is compatible with the lack of knockout
mouse models for this enzyme. Our description of
a human-inherited disease associated with functional deﬁ-
ciency of MBTPS2 opens a new avenue for studying the
role of this important intramembrane protease.
Supplemental Data
Supplemental data include two tables and one ﬁgure and can be
found with this article at http://www.ajhg.org/.
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